1. Home
  2. ATAI vs GSRT Comparison

ATAI vs GSRT Comparison

Compare ATAI & GSRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • GSRT
  • Stock Information
  • Founded
  • ATAI 2018
  • GSRT 2023
  • Country
  • ATAI Germany
  • GSRT United States
  • Employees
  • ATAI N/A
  • GSRT N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • GSRT
  • Sector
  • ATAI Health Care
  • GSRT
  • Exchange
  • ATAI Nasdaq
  • GSRT Nasdaq
  • Market Cap
  • ATAI 444.7M
  • GSRT 316.5M
  • IPO Year
  • ATAI 2021
  • GSRT 2024
  • Fundamental
  • Price
  • ATAI $2.65
  • GSRT $10.94
  • Analyst Decision
  • ATAI Strong Buy
  • GSRT
  • Analyst Count
  • ATAI 2
  • GSRT 0
  • Target Price
  • ATAI $11.00
  • GSRT N/A
  • AVG Volume (30 Days)
  • ATAI 6.0M
  • GSRT 948.0K
  • Earning Date
  • ATAI 08-12-2025
  • GSRT 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • GSRT N/A
  • EPS Growth
  • ATAI N/A
  • GSRT N/A
  • EPS
  • ATAI N/A
  • GSRT 0.14
  • Revenue
  • ATAI $1,863,000.00
  • GSRT N/A
  • Revenue This Year
  • ATAI $554.22
  • GSRT N/A
  • Revenue Next Year
  • ATAI N/A
  • GSRT N/A
  • P/E Ratio
  • ATAI N/A
  • GSRT $77.12
  • Revenue Growth
  • ATAI 572.56
  • GSRT N/A
  • 52 Week Low
  • ATAI $1.03
  • GSRT $9.86
  • 52 Week High
  • ATAI $2.99
  • GSRT $11.49
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 58.75
  • GSRT N/A
  • Support Level
  • ATAI $2.53
  • GSRT N/A
  • Resistance Level
  • ATAI $2.79
  • GSRT N/A
  • Average True Range (ATR)
  • ATAI 0.21
  • GSRT 0.00
  • MACD
  • ATAI 0.00
  • GSRT 0.00
  • Stochastic Oscillator
  • ATAI 64.55
  • GSRT 0.00

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About GSRT GSR III Acquisition Corp. Ordinary Shares

GSR III Acquisition Corp is a blank check company.

Share on Social Networks: